|
Volumn 153, Issue 1, 2010, Pages 51-52
|
Aggregating and disaggregating patients in clinical trials and their subgroup analyses
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ENOXAPARIN;
ANTICOAGULANT AGENT;
BLEEDING;
EDITORIAL;
HIGH RISK PATIENT;
PRIORITY JOURNAL;
RISK FACTOR;
TREATMENT DURATION;
VENOUS THROMBOEMBOLISM;
ACUTE DISEASE;
DELAYED RELEASE FORMULATION;
HUMAN;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
STANDARD;
STATISTICAL ANALYSIS;
WALKING DIFFICULTY;
ACUTE DISEASE;
ANTICOAGULANTS;
DATA INTERPRETATION, STATISTICAL;
DELAYED-ACTION PREPARATIONS;
ENOXAPARIN;
HUMANS;
MOBILITY LIMITATION;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK ASSESSMENT;
VENOUS THROMBOEMBOLISM;
|
EID: 77955909163
PISSN: 00034819
EISSN: 15393704
Source Type: Journal
DOI: 10.7326/0003-4819-153-1-201007060-00012 Document Type: Editorial |
Times cited : (16)
|
References (6)
|